Bajaj Finserv Healthcare Fund Regular-idcw

  • 3 Months
  • 6 Months
  • 1 Year
  • 3 Years
  • 5 Years
  • RSI
3 Months Returns : 1.82%
NAV: ₹9.86 as on Fri Oct 17, 2025
Fund NAV

Fund Overview of Bajaj Finserv Healthcare Fund Regular-idcw

  • ₹341.3 Cr
    AUM
  • ₹9.86
    NAV
  • 2.38%
    Expense Ratio
  • Equity
    Fund Category
As on Fri Oct 17, 2025

Returns of Bajaj Finserv Healthcare Fund Regular-idcw

Tenure Absolute(%) Annualised(%) Category Average(%)
3 Months 1.82% NA 6.12%
6 Months 12.99% NA 12.92%
As on Fri Oct 17, 2025

Asset Allocation

equities

98.75%

debt instruments

2.97%
Large Cap: 41.82%
Mid Cap: 22.83%
Small Cap: 35.35%
Other: 0.00%
Top Holdings
Divi's Laboratories Ltd
7.94%
Sun Pharmaceutical Industries Ltd
7.48%
Divi's Laboratories Ltd
7.75%
Divi's Laboratories Ltd
7.75%
Sun Pharmaceutical Industries Ltd
7.53%
 
Top Sectors
Healthcare
260.33%
Consumer Staples
21.71%
Materials
5.82%
Unspecified
5.75%
Industrials
4.83%
Detailed Portfolio Analysis
As on Fri Oct 17, 2025
Invest Now

About Fund

About Bajaj Finserv Healthcare Fund Regular-idcw

Bajaj Finserv Healthcare Fund Regular-idcw is one Equity mutual fund offered by Bajaj Finserv Mutual Fund. Launched on 27 Dec 2024, the fund aims Wealth creation over long term. To invest predominantly in equity and equity related instruments of pharma, healthcare and allied companies. It manages assets worth ₹341.3 crore as on Thu Jul 31, 2025. The expense ratio stands at 2.38%.
The portfolio allocation consists of 98.75% in equities, 2.97% in debt instruments. Managed by Sorbh Gupta, it has delivered a return of 0.00% in the last year, a total return since inception of -1.33%.

Read more
  • Nimesh Chandan

    Fund Manager

  • Mr. Chandan is an MBA in Finance.

    Manager Education

  • Siddharth Chaudhary

    Fund Manager

  • Mr. Chaudhary is a B.Com (H) and PGDM (Securities Markets).

    Manager Education

  • Sorbh Gupta

    Fund Manager

  • Mr. Gupta is a B.Com, CA and CFA.

    Manager Education

Fund Details

Fund Names Bajaj Finserv Healthcare Fund Regular-idcw
Inception Date 27 Dec 2024
Lock In No Lock-in
SIP Minimum Investment amount ₹ 500
SWP Minimum Investment amount ₹ 1000
STP Minimum Investment amount ₹ 500
 
Risk Principal at very high risk
Category Average Annual Returns 6.04
More Details
Highest NAV in last 52 weeks & Lowest NAV in last 52 weeks

Top Performing Mutual Funds

Fund Names AUM (Cr) 1M 3M 1Yr 3Yr 5Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 -0.73% -0.53% 3.49% 29.11% 21.35%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 -0.81% -0.74% 2.62% 28.00% 20.28%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 -0.32% 0.29% -2.50% 23.52% 17.19%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 -0.41% -0.03% -3.76% 21.87% 15.52%
increase growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns

More funds from Bajaj Finserv Mutual Fund

Fund Names AUM (Cr) 1M 3M 6M 1Yr 3Yr
Bajaj Finserv Healthcare Fund Direct-growth increase ₹341 -0.75% -0.52% 8.48% - -
Bajaj Finserv Healthcare Fund Regular-growth increase ₹341 -0.88% -0.93% 7.56% - -
Bajaj Finserv Healthcare Fund Direct-idcw increase ₹341 -0.75% -0.52% 8.48% - -
increase growth is based on 1-month returns of the funds

Mutual Fund Calculator

I want to invest Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Total Wealth
Start Investing
I want to save
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Monthly Investment
Invest Now
You can also get Tax Free Maturity/ Returns? You can also get Tax Free Maturity/ Returns?

Top Mutual Funds

Fund Names AUM (Cr) NAV 3Yr 5Yr 10Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 ₹43.62 29.11% 21.35% -
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 ₹40.40 28.00% 20.28% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 ₹31.25 21.87% 15.52% -
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 ₹34.42 23.52% 17.19% -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.25 22.46% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.25 22.46% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.25 22.46% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.25 22.46% - -
View More
Top funds are based on Fund AUM

Detailed Portfolio

Stocks Sector % of Holding Value
Divi's Laboratories LtdHealthcare7.94%₹27.09 Cr
Sun Pharmaceutical Industries LtdHealthcare7.48%₹25.54 Cr
Divi's Laboratories LtdHealthcare7.75%₹25.00 Cr
Divi's Laboratories LtdHealthcare7.75%₹25.00 Cr
Sun Pharmaceutical Industries LtdHealthcare7.53%₹24.27 Cr
Sun Pharmaceutical Industries LtdHealthcare7.53%₹24.27 Cr
Apollo Hospitals Enterprise LtdHealthcare6.01%₹20.51 Cr
Apollo Hospitals Enterprise LtdHealthcare6.29%₹20.27 Cr
Apollo Hospitals Enterprise LtdHealthcare6.29%₹20.27 Cr
Cipla LtdHealthcare5.32%₹18.16 Cr
Cipla LtdHealthcare5.45%₹17.56 Cr
Cipla LtdHealthcare5.45%₹17.56 Cr
Biocon LtdHealthcare3.76%₹12.82 Cr
Fortis Healthcare LtdHealthcare3.83%₹12.36 Cr
Fortis Healthcare LtdHealthcare3.83%₹12.36 Cr
Neuland Laboratories LtdHealthcare3.78%₹12.18 Cr
Neuland Laboratories LtdHealthcare3.78%₹12.18 Cr
Glenmark Pharmaceuticals LtdHealthcare3.45%₹11.76 Cr
Biocon LtdHealthcare3.59%₹11.58 Cr
Biocon LtdHealthcare3.59%₹11.58 Cr
Emcure Pharmaceuticals Ltd.Healthcare3.39%₹11.56 Cr
Dr. Reddy's Laboratories LtdHealthcare3.37%₹11.49 Cr
Aurobindo Pharma Limited October 2025 FutureHealthcare3.44%₹11.08 Cr
Aurobindo Pharma Limited October 2025 FutureHealthcare3.44%₹11.08 Cr
Syngene International LtdHealthcare3.25%₹11.08 Cr
Dr. Reddy's Laboratories LtdHealthcare3.43%₹11.07 Cr
Dr. Reddy's Laboratories LtdHealthcare3.43%₹11.07 Cr
Fortis Healthcare LtdHealthcare3.20%₹10.92 Cr
Piramal Pharma LtdHealthcare3.15%₹10.74 Cr
Net ReceivablesUnspecified3.08%₹10.59 Cr
Dr. Lal Pathlabs LtdHealthcare3.09%₹10.54 Cr
Emcure Pharmaceuticals Ltd.Healthcare3.26%₹10.50 Cr
Emcure Pharmaceuticals Ltd.Healthcare3.26%₹10.50 Cr
Dr. Lal Pathlabs LtdHealthcare3.24%₹10.43 Cr
Dr. Lal Pathlabs LtdHealthcare3.24%₹10.43 Cr
Piramal Pharma LtdHealthcare3.23%₹10.42 Cr
Piramal Pharma LtdHealthcare3.23%₹10.42 Cr
Neuland Laboratories LtdHealthcare3.00%₹10.24 Cr
Aurobindo Pharma LtdHealthcare3.15%₹10.16 Cr
Aurobindo Pharma LtdHealthcare3.15%₹10.16 Cr
Aurobindo Pharma LtdHealthcare2.89%₹9.88 Cr
Others CbloUnspecified2.97%₹9.58 Cr
Others CbloUnspecified2.97%₹9.58 Cr
Glenmark Pharmaceuticals LtdHealthcare2.97%₹9.56 Cr
Glenmark Pharmaceuticals LtdHealthcare2.97%₹9.56 Cr
Pfizer LtdHealthcare2.48%₹8.48 Cr
Torrent Pharmaceuticals LtdHealthcare2.42%₹8.26 Cr
Pfizer LtdHealthcare2.55%₹8.22 Cr
Pfizer LtdHealthcare2.55%₹8.22 Cr
Ipca Laboratories LtdHealthcare2.18%₹7.44 Cr
Lupin LtdHealthcare2.05%₹7.00 Cr
Lupin LtdHealthcare2.15%₹6.93 Cr
Lupin LtdHealthcare2.15%₹6.93 Cr
Ipca Laboratories LtdHealthcare2.10%₹6.76 Cr
Ipca Laboratories LtdHealthcare2.10%₹6.76 Cr
Vijaya Diagnostic Centre LtdHealthcare1.94%₹6.63 Cr
Sanofi Consumer Healthcare India LtdHealthcare2.03%₹6.54 Cr
Sanofi Consumer Healthcare India LtdHealthcare2.03%₹6.54 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare1.86%₹6.34 Cr
Zydus Wellness LtdConsumer Staples1.96%₹6.31 Cr
Zydus Wellness LtdConsumer Staples1.96%₹6.31 Cr
Godrej Consumer Products LtdConsumer Staples1.84%₹6.30 Cr
Sanofi Consumer Healthcare India LtdHealthcare1.82%₹6.22 Cr
Vijaya Diagnostic Centre LtdHealthcare1.91%₹6.17 Cr
Vijaya Diagnostic Centre LtdHealthcare1.91%₹6.17 Cr
Abbott India LtdHealthcare1.75%₹5.98 Cr
Godrej Consumer Products LtdConsumer Staples1.81%₹5.83 Cr
Godrej Consumer Products LtdConsumer Staples1.81%₹5.83 Cr
Zydus Wellness LtdConsumer Staples1.64%₹5.60 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare1.73%₹5.57 Cr
Glaxosmithkline Pharmaceuticals LtdHealthcare1.73%₹5.57 Cr
Hindustan Unilever LtdConsumer Staples1.60%₹5.46 Cr
Shaily Engineering Plastics LtdMaterials1.68%₹5.40 Cr
Shaily Engineering Plastics LtdMaterials1.68%₹5.40 Cr
Medi Assist Healthcare Services Ltd.Industrials1.57%₹5.36 Cr
Medi Assist Healthcare Services Ltd.Industrials1.63%₹5.25 Cr
Medi Assist Healthcare Services Ltd.Industrials1.63%₹5.25 Cr
Alkem Laboratories LtdHealthcare1.61%₹5.18 Cr
Alkem Laboratories LtdHealthcare1.61%₹5.18 Cr
Abbott India LtdHealthcare1.58%₹5.09 Cr
Abbott India LtdHealthcare1.58%₹5.09 Cr
Alkem Laboratories LtdHealthcare1.41%₹4.81 Cr
Medplus Health Services LtdHealthcare1.41%₹4.81 Cr
Torrent Pharmaceuticals LtdHealthcare1.42%₹4.57 Cr
Torrent Pharmaceuticals LtdHealthcare1.42%₹4.57 Cr
Emami LtdConsumer Staples1.33%₹4.53 Cr
Rainbow Childrens Medicare LtdHealthcare1.32%₹4.50 Cr
Max Healthcare Institute LtdHealthcare1.28%₹4.36 Cr
Jubilant Pharmova LtdHealthcare1.22%₹4.18 Cr
Rainbow Childrens Medicare LtdHealthcare1.24%₹4.00 Cr
Rainbow Childrens Medicare LtdHealthcare1.24%₹4.00 Cr
Shaily Engineering Plastics LtdMaterials1.15%₹3.94 Cr
Hindustan Unilever LtdConsumer Staples1.22%₹3.92 Cr
Hindustan Unilever LtdConsumer Staples1.22%₹3.92 Cr
Medplus Health Services LtdHealthcare1.21%₹3.91 Cr
Medplus Health Services LtdHealthcare1.21%₹3.91 Cr
Alembic Pharmaceuticals LtdHealthcare1.14%₹3.91 Cr
Max Healthcare Institute LtdHealthcare1.21%₹3.90 Cr
Max Healthcare Institute LtdHealthcare1.21%₹3.90 Cr
Jubilant Pharmova LtdHealthcare1.17%₹3.78 Cr
Jubilant Pharmova LtdHealthcare1.17%₹3.78 Cr
Mankind Pharma Ltd.Healthcare1.09%₹3.73 Cr
Alembic Pharmaceuticals LtdHealthcare1.12%₹3.60 Cr
Alembic Pharmaceuticals LtdHealthcare1.12%₹3.60 Cr
Mankind Pharma Ltd.Healthcare1.10%₹3.54 Cr
Mankind Pharma Ltd.Healthcare1.10%₹3.54 Cr
Syngene International LtdHealthcare1.07%₹3.43 Cr
Syngene International LtdHealthcare1.07%₹3.43 Cr
Astrazeneca Pharma India LtdHealthcare0.88%₹3.00 Cr
Astrazeneca Pharma India LtdHealthcare0.92%₹2.97 Cr
Astrazeneca Pharma India LtdHealthcare0.92%₹2.97 Cr
Emami LtdConsumer Staples0.92%₹2.96 Cr
Emami LtdConsumer Staples0.92%₹2.96 Cr
Marico LtdConsumer Staples0.66%₹2.24 Cr
Marico LtdConsumer Staples0.68%₹2.20 Cr
Marico LtdConsumer Staples0.68%₹2.20 Cr
Pb Fintech LtdFinancial0.52%₹1.78 Cr
Pb Fintech LtdFinancial0.52%₹1.67 Cr
Pb Fintech LtdFinancial0.52%₹1.67 Cr
Nestle India LtdConsumer Staples0.50%₹1.60 Cr
Nestle India LtdConsumer Staples0.50%₹1.60 Cr
Nestle India LtdConsumer Staples0.46%₹1.56 Cr
Neogen Chemicals LtdMaterials0.43%₹1.45 Cr
Neogen Chemicals LtdMaterials0.44%₹1.42 Cr
Neogen Chemicals LtdMaterials0.44%₹1.42 Cr
Suven Pharmaceuticals LtdHealthcare0.33%₹1.05 Cr
Suven Pharmaceuticals LtdHealthcare0.33%₹1.05 Cr
Others CbloUnspecified0.17%₹0.57 Cr
Net PayablesUnspecified-1.72%₹-5.39 Cr
Net PayablesUnspecified-1.72%₹-5.39 Cr
View More

Top Equity Funds

Fund Names NAV 3Yr 5Yr 52 weeks high
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹43.62 29.11% 21.35% 44.69
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹40.40 28.00% 20.28% 41.47
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth increase ₹34.42 23.52% 17.19% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth increase ₹31.25 21.87% 15.52% -
increase growth is based on 5Y returns of the funds

Frequently Asked Questions

Bajaj Finserv Healthcare Fund Regular-idcw

What is the current AUM of Bajaj Finserv Healthcare Fund Regular-idcw?

As of Thu Jul 31, 2025, Bajaj Finserv Healthcare Fund Regular-idcw manages assets worth ₹341.3 crore

How has Bajaj Finserv Healthcare Fund Regular-idcw performed recently?

  • 3 Months: 1.82%
  • 6 Months: 12.99%

What is the portfolio composition of Bajaj Finserv Healthcare Fund Regular-idcw?

Equity: 98.75%, Debt: 2.97%, Others: -1.72%.

Who manages Bajaj Finserv Healthcare Fund Regular-idcw?

Bajaj Finserv Healthcare Fund Regular-idcw is managed by Sorbh Gupta from Bajaj Finserv Mutual Fund.

What is the market-cap allocation of Bajaj Finserv Healthcare Fund Regular-idcw?

Large Cap: 41.82%, Mid Cap: 22.83%, Small Cap: 35.35%.

Which are the top companies Bajaj Finserv Healthcare Fund Regular-idcw has invested in?

  • Divi's Laboratories Ltd – 7.94% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 7.48% of the fund's portfolio
  • Divi's Laboratories Ltd – 7.75% of the fund's portfolio
  • Divi's Laboratories Ltd – 7.75% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 7.53% of the fund's portfolio

Which are the major sectors Bajaj Finserv Healthcare Fund Regular-idcw focuses on?

  • Healthcare – 260.33% of the fund's portfolio
  • Consumer Staples – 21.71% of the fund's portfolio
  • Materials – 5.82% of the fund's portfolio
  • Unspecified – 5.75% of the fund's portfolio
  • Industrials – 4.83% of the fund's portfolio
View more FAQ's

Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.

Please consult your financial advisor for an informed decision.

Past performance may not be indicative of future results.

The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.

Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.

Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.

For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.

For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.

Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved

^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.

Explore the popular searches and stay informed

Close
Download the Policybazaar app
to manage all your insurance needs.
INSTALL
Claude
top

Become a Crorepati

Invest ₹10K/Month & Get ₹1 Crore# Returns

Mobile +91
*T&C Applied.